Trial Profile
Prospective study investigating the effect of intravitreal ranibizumab injections on retinal vessels in patients with diabetic macular oedema (DME)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Pharmacodynamics
- 27 Nov 2015 New trial record